Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800540424> ?p ?o ?g. }
- W2800540424 endingPage "161" @default.
- W2800540424 startingPage "152" @default.
- W2800540424 abstract "Severe allergic ocular diseases as atopic keratoconjunctivitis can induce corneal damage due to inflammatory substances released from giant papillae. Tacrolimus eye drops are one of the current therapeutic alternatives for its treatment. This work is aimed at developing and characterizing a 0.03% tacrolimus ophthalmic formulation, which was introduced in three types of vehicles (BBS, PVA and Hyaluronic Acid). For this, we have performed in vitro (stability studies) and in vivo assays (corneal permanence time measured directly by Positron Emission Tomography) of three potential formulations. Next, the best formulation was selected, and its toxicological profile and clinical effectiveness have been evaluated. The biopermanence studies (direct measurements and PET/CT) showed that the formulations with PVA and Hyaluronic Acid present more retention time on the ocular surface of rats than PBS. From the stability study, we have determined that tacrolimus with PVA in cold storage is the best option. Tacrolimus with PVA has shown lower cytotoxicity than cyclosporine at early times. On the other hand, the pilot study performed has shown significant improvements in patients, with no noticeable adverse reactions. Based on stability, biopermanence, safety and clinical effectiveness studies, we concluded that tacrolimus-PVA eye drops are a suitable candidate for its clinical application in inflammatory ophthalmology diseases." @default.
- W2800540424 created "2018-05-17" @default.
- W2800540424 creator A5027637432 @default.
- W2800540424 creator A5027872797 @default.
- W2800540424 creator A5032939136 @default.
- W2800540424 creator A5036433601 @default.
- W2800540424 creator A5037362839 @default.
- W2800540424 creator A5040366258 @default.
- W2800540424 creator A5042711303 @default.
- W2800540424 creator A5050661232 @default.
- W2800540424 creator A5063100308 @default.
- W2800540424 creator A5066835339 @default.
- W2800540424 creator A5067612645 @default.
- W2800540424 creator A5076523840 @default.
- W2800540424 creator A5081649249 @default.
- W2800540424 creator A5087260595 @default.
- W2800540424 creator A5088635476 @default.
- W2800540424 date "2018-07-01" @default.
- W2800540424 modified "2023-09-27" @default.
- W2800540424 title "Preclinical characterization and clinical evaluation of tacrolimus eye drops" @default.
- W2800540424 cites W10043197 @default.
- W2800540424 cites W162422877 @default.
- W2800540424 cites W1822221617 @default.
- W2800540424 cites W1828452947 @default.
- W2800540424 cites W1867739297 @default.
- W2800540424 cites W1957937187 @default.
- W2800540424 cites W1965538727 @default.
- W2800540424 cites W1974947034 @default.
- W2800540424 cites W1978095627 @default.
- W2800540424 cites W1981110885 @default.
- W2800540424 cites W1981275525 @default.
- W2800540424 cites W1984754431 @default.
- W2800540424 cites W1985107831 @default.
- W2800540424 cites W1987855853 @default.
- W2800540424 cites W1991636257 @default.
- W2800540424 cites W1993958396 @default.
- W2800540424 cites W1996042193 @default.
- W2800540424 cites W2006994476 @default.
- W2800540424 cites W2007221575 @default.
- W2800540424 cites W2009814734 @default.
- W2800540424 cites W2020257494 @default.
- W2800540424 cites W2021204961 @default.
- W2800540424 cites W2035060637 @default.
- W2800540424 cites W2038075308 @default.
- W2800540424 cites W2047855993 @default.
- W2800540424 cites W2049724441 @default.
- W2800540424 cites W2051839108 @default.
- W2800540424 cites W2054818932 @default.
- W2800540424 cites W2054896232 @default.
- W2800540424 cites W2063379502 @default.
- W2800540424 cites W2063909696 @default.
- W2800540424 cites W2065374943 @default.
- W2800540424 cites W2074984233 @default.
- W2800540424 cites W2077841704 @default.
- W2800540424 cites W2084512992 @default.
- W2800540424 cites W2085612857 @default.
- W2800540424 cites W2102551042 @default.
- W2800540424 cites W2109278620 @default.
- W2800540424 cites W2140657586 @default.
- W2800540424 cites W2148253202 @default.
- W2800540424 cites W2149174813 @default.
- W2800540424 cites W2178783734 @default.
- W2800540424 cites W2228217441 @default.
- W2800540424 cites W2238268591 @default.
- W2800540424 cites W2256034604 @default.
- W2800540424 cites W2314817664 @default.
- W2800540424 cites W2319000063 @default.
- W2800540424 cites W2324350546 @default.
- W2800540424 cites W2381631717 @default.
- W2800540424 cites W2469011180 @default.
- W2800540424 cites W2471500691 @default.
- W2800540424 cites W2551481732 @default.
- W2800540424 cites W2593076288 @default.
- W2800540424 cites W2603809109 @default.
- W2800540424 cites W2607427523 @default.
- W2800540424 cites W2666616724 @default.
- W2800540424 cites W2722391305 @default.
- W2800540424 cites W4238751177 @default.
- W2800540424 cites W4243691022 @default.
- W2800540424 doi "https://doi.org/10.1016/j.ejps.2018.04.038" @default.
- W2800540424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29705214" @default.
- W2800540424 hasPublicationYear "2018" @default.
- W2800540424 type Work @default.
- W2800540424 sameAs 2800540424 @default.
- W2800540424 citedByCount "16" @default.
- W2800540424 countsByYear W28005404242019 @default.
- W2800540424 countsByYear W28005404242020 @default.
- W2800540424 countsByYear W28005404242021 @default.
- W2800540424 countsByYear W28005404242022 @default.
- W2800540424 countsByYear W28005404242023 @default.
- W2800540424 crossrefType "journal-article" @default.
- W2800540424 hasAuthorship W2800540424A5027637432 @default.
- W2800540424 hasAuthorship W2800540424A5027872797 @default.
- W2800540424 hasAuthorship W2800540424A5032939136 @default.
- W2800540424 hasAuthorship W2800540424A5036433601 @default.
- W2800540424 hasAuthorship W2800540424A5037362839 @default.
- W2800540424 hasAuthorship W2800540424A5040366258 @default.
- W2800540424 hasAuthorship W2800540424A5042711303 @default.